메뉴 건너뛰기




Volumn 220, Issue 1, 2012, Pages 184-188

Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism

Author keywords

Lipid lowering drugs; Lipids; Risk factors; Venous thromboembolism

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 84155172196     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.007     Document Type: Article
Times cited : (28)

References (30)
  • 1
    • 0037431022 scopus 로고    scopus 로고
    • An association between atherosclerosis and venous thrombosis
    • Prandoni P., Bilora F., Marchiori A., et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003, 348:1435-1441.
    • (2003) N Engl J Med , vol.348 , pp. 1435-1441
    • Prandoni, P.1    Bilora, F.2    Marchiori, A.3
  • 2
    • 33747151899 scopus 로고    scopus 로고
    • Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis
    • Prandoni P., Ghirarduzzi A., Prins M.H., et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006, 4:1891-1896.
    • (2006) J Thromb Haemost , vol.4 , pp. 1891-1896
    • Prandoni, P.1    Ghirarduzzi, A.2    Prins, M.H.3
  • 3
    • 36248998300 scopus 로고    scopus 로고
    • Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study
    • Sorensen H.T., Horvath-Puho E., Pedersen L., Baron J.A., Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007, 370:1773-1779.
    • (2007) Lancet , vol.370 , pp. 1773-1779
    • Sorensen, H.T.1    Horvath-Puho, E.2    Pedersen, L.3    Baron, J.A.4    Prandoni, P.5
  • 4
    • 37349104557 scopus 로고    scopus 로고
    • Cardiovascular risk factors and venous thromboembolism: a meta-analysis
    • Ageno W., Becattini C., Brighton T., Selby R., Kamphuisen P.W. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008, 117:93-102.
    • (2008) Circulation , vol.117 , pp. 93-102
    • Ageno, W.1    Becattini, C.2    Brighton, T.3    Selby, R.4    Kamphuisen, P.W.5
  • 5
    • 0034919598 scopus 로고    scopus 로고
    • Use of statins and the subsequent development of deep vein thrombosis
    • Ray J.G., Mamdani M., Tsuyuki R.T., et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001, 161:1405-1410.
    • (2001) Arch Intern Med , vol.161 , pp. 1405-1410
    • Ray, J.G.1    Mamdani, M.2    Tsuyuki, R.T.3
  • 6
    • 0037173078 scopus 로고    scopus 로고
    • Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
    • Herrington D.M., Vittinghoff E., Lin F., et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002, 105:2962-2967.
    • (2002) Circulation , vol.105 , pp. 2962-2967
    • Herrington, D.M.1    Vittinghoff, E.2    Lin, F.3
  • 7
    • 4744342682 scopus 로고    scopus 로고
    • HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women
    • Doggen C.J., Lemaitre R.N., Smith N.L., Heckbert S.R., Psaty B.M. HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2004, 2:700-701.
    • (2004) J Thromb Haemost , vol.2 , pp. 700-701
    • Doggen, C.J.1    Lemaitre, R.N.2    Smith, N.L.3    Heckbert, S.R.4    Psaty, B.M.5
  • 8
    • 4544290791 scopus 로고    scopus 로고
    • Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study
    • Lacut K., Oger E., Le Gal G., et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol 2004, 18:477-482.
    • (2004) Fundam Clin Pharmacol , vol.18 , pp. 477-482
    • Lacut, K.1    Oger, E.2    Le Gal, G.3
  • 9
    • 63049128422 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis
    • Ramcharan A.S., Van Stralen K.J., Snoep J.D., et al. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. J Thromb Haemost 2009, 7:514-520.
    • (2009) J Thromb Haemost , vol.7 , pp. 514-520
    • Ramcharan, A.S.1    Van Stralen, K.J.2    Snoep, J.D.3
  • 10
    • 63049121906 scopus 로고    scopus 로고
    • Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study
    • Sorensen H.T., Horvath-Puho E., Sogaard K.K., et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 2009, 7:521-528.
    • (2009) J Thromb Haemost , vol.7 , pp. 521-528
    • Sorensen, H.T.1    Horvath-Puho, E.2    Sogaard, K.K.3
  • 11
    • 65449138698 scopus 로고    scopus 로고
    • A randomized trial of rosuvastatin in the prevention of venous thromboembolism
    • Glynn R.J., Danielson E., Fonseca F.A., et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009, 360:1851-1861.
    • (2009) N Engl J Med , vol.360 , pp. 1851-1861
    • Glynn, R.J.1    Danielson, E.2    Fonseca, F.A.3
  • 12
    • 23844474503 scopus 로고    scopus 로고
    • High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men
    • Deguchi H., Pecheniuk N.M., Elias D.J., Averell P.M., Griffin J.H. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005, 112:893-899.
    • (2005) Circulation , vol.112 , pp. 893-899
    • Deguchi, H.1    Pecheniuk, N.M.2    Elias, D.J.3    Averell, P.M.4    Griffin, J.H.5
  • 13
    • 0033552139 scopus 로고    scopus 로고
    • Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913
    • Hansson P.-O., Eriksson H., Welin L., Svardsudd K., Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913. Arch Intern Med 1999, 159:1886-1890.
    • (1999) Arch Intern Med , vol.159 , pp. 1886-1890
    • Hansson, P.-O.1    Eriksson, H.2    Welin, L.3    Svardsudd, K.4    Wilhelmsen, L.5
  • 15
    • 0141702136 scopus 로고    scopus 로고
    • The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism
    • Gonzalez-Ordonez A.J., Fernandez-Carreira J.M., Fernandez-Alvarez C.R., et al. The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism. Haematologica 2003, 88:1035-1043.
    • (2003) Haematologica , vol.88 , pp. 1035-1043
    • Gonzalez-Ordonez, A.J.1    Fernandez-Carreira, J.M.2    Fernandez-Alvarez, C.R.3
  • 16
    • 0030737433 scopus 로고    scopus 로고
    • Hypercholesterolemia as a risk factor for deep-vein thrombosis
    • Kawasaki T., Kambayashi J., Ariyoshi H., et al. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 1997, 88:67-73.
    • (1997) Thromb Res , vol.88 , pp. 67-73
    • Kawasaki, T.1    Kambayashi, J.2    Ariyoshi, H.3
  • 17
    • 0034035948 scopus 로고    scopus 로고
    • Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism
    • McColl M.D., Sattar N., Ellison J., et al. Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis 2000, 11:225-229.
    • (2000) Blood Coagul Fibrinolysis , vol.11 , pp. 225-229
    • McColl, M.D.1    Sattar, N.2    Ellison, J.3
  • 18
    • 0037182012 scopus 로고    scopus 로고
    • Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology
    • Tsai A.W., Cushman M., Rosamond W.D., et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002, 162:1182-1189.
    • (2002) Arch Intern Med , vol.162 , pp. 1182-1189
    • Tsai, A.W.1    Cushman, M.2    Rosamond, W.D.3
  • 19
    • 0036065173 scopus 로고    scopus 로고
    • Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors
    • Vaya A., Mira Y., Ferrando F., et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002, 118:255-259.
    • (2002) Br J Haematol , vol.118 , pp. 255-259
    • Vaya, A.1    Mira, Y.2    Ferrando, F.3
  • 20
    • 33644986404 scopus 로고    scopus 로고
    • Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study
    • Oger E., Lacut K., Le Gal G., et al. Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost 2006, 4:793-799.
    • (2006) J Thromb Haemost , vol.4 , pp. 793-799
    • Oger, E.1    Lacut, K.2    Le Gal, G.3
  • 21
    • 53449100859 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE)
    • Chamberlain A.M., Folsom A.R., Heckbert S.R., Rosamond W.D., Cushman M. High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood 2008, 112:2675-2680.
    • (2008) Blood , vol.112 , pp. 2675-2680
    • Chamberlain, A.M.1    Folsom, A.R.2    Heckbert, S.R.3    Rosamond, W.D.4    Cushman, M.5
  • 22
    • 65349192347 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology
    • Steffen L.M., Cushman M., Peacock J.M., et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost 2009, 7:746-751.
    • (2009) J Thromb Haemost , vol.7 , pp. 746-751
    • Steffen, L.M.1    Cushman, M.2    Peacock, J.M.3
  • 23
    • 17144429309 scopus 로고    scopus 로고
    • Hyperhomocysteinaemia, hyperlipidaemia and risk of venous thromboembolism in Shiraz
    • Zamani A., Omrani G.R., Lankarani K.B. Hyperhomocysteinaemia, hyperlipidaemia and risk of venous thromboembolism in Shiraz. East Mediterr Health J 2003, 9:935-943.
    • (2003) East Mediterr Health J , vol.9 , pp. 935-943
    • Zamani, A.1    Omrani, G.R.2    Lankarani, K.B.3
  • 24
    • 8644284226 scopus 로고    scopus 로고
    • Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
    • Frederiksen J., Juul K., Grande P., et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood 2004, 104:3046-3051.
    • (2004) Blood , vol.104 , pp. 3046-3051
    • Frederiksen, J.1    Juul, K.2    Grande, P.3
  • 25
    • 63049109006 scopus 로고    scopus 로고
    • Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women
    • Everett B.M., Glynn R.J., Buring J.E., Ridker P.M. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost 2009, 7:588-596.
    • (2009) J Thromb Haemost , vol.7 , pp. 588-596
    • Everett, B.M.1    Glynn, R.J.2    Buring, J.E.3    Ridker, P.M.4
  • 26
    • 33645997399 scopus 로고    scopus 로고
    • The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence
    • Walldius G., Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 2006, 259:493-519.
    • (2006) J Intern Med , vol.259 , pp. 493-519
    • Walldius, G.1    Jungner, I.2
  • 28
  • 29
    • 0029918398 scopus 로고    scopus 로고
    • Changes in plasma cholesterol levels after hospitalization for acute coronary events
    • Brugada R., Wenger N.K., Jacobson T.A., et al. Changes in plasma cholesterol levels after hospitalization for acute coronary events. Cardiology 1996, 87:194-199.
    • (1996) Cardiology , vol.87 , pp. 194-199
    • Brugada, R.1    Wenger, N.K.2    Jacobson, T.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.